Literature DB >> 8537110

HLA-A null allele with a stop codon, HLA-A*0215N, identified in a homozygous state in a healthy adult.

Y Ishikawa1, K Tokunaga, H Tanaka, M Nishimura, M Muraoka, Y Fujii, T Akaza, K Tadokoro, T Juji.   

Abstract

A healthy adult having no serologically detectable HLA class I A locus antigens was identified. The parents of the individual are consanguineous. Results of a family study indicated that the individual is homozygous for the B46-Cw1-DR8.1 haplotype, which was shown to be positively associated with A*0207 in our previous study. The HLA-A null individual is healthy and exhibits no apparent immunological abnormality. Total RNAs extracted from peripheral blood were converted to cDNAs. The reverse transcriptase-polymerase chain reaction (PCR) product, which is of the same size as the normally expressed gene, was easily obtained from the cDNAs with HLA-A locus-specific primers. The nucleotide sequence of this null allele (A*0215N) was the same as that of A*0207 except for a single nucleotide substitution which resulted in a stop codon in exon 4. From its nucleotide sequence, a truncated molecule was expected to be produced; however, the immunoprecipitation study failed to detect the predicted product. Genomic DNAs from 29 unrelated individuals who expressed only one HLA-A antigen with HLA-B46, were analyzed by a PCR-sequence-specific oligonucleotide method. None of the samples possessed this stop codon. Therefore, A*0215N is likely to be a rare allele generated by a single point mutation from A*0207.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8537110     DOI: 10.1007/bf00186597

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  8 in total

1.  cis-acting regulatory elements abrogate allele-specific HLA class I gene expression in healthy individuals.

Authors:  N M Lardy; R M Bakas; A R van der Horst; E van Twuyver; R E Bontrop; L P de Waal
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

2.  HLA class I nucleotide sequences, 1991.

Authors:  J Zemmour; P Parham
Journal:  Hum Immunol       Date:  1991-07       Impact factor: 2.850

3.  Molecular analysis of HLA-A2.4 functional variant KLO: close structural and evolutionary relatedness to the HLA-A2.2 subtype.

Authors:  N Doménech; R Castaño; E Goulmy; J A López de Castro
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

Review 4.  Antigen recognition by class I-restricted T lymphocytes.

Authors:  A Townsend; H Bodmer
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

5.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

6.  Sequence-based typing of HLA-A2 alleles using a primer with an extra base mismatch.

Authors:  Y Ishikawa; K Tokunaga; K Kashiwase; T Akaza; K Tadokoro; T Juji
Journal:  Hum Immunol       Date:  1995-04       Impact factor: 2.850

7.  Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens.

Authors:  P Parham; C J Barnstable; W F Bodmer
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

8.  An altered splice site is found in the DRB4 gene that is not expressed in HLA-DR7,Dw11 individuals.

Authors:  V R Sutton; B K Kienzle; R W Knowles
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

  8 in total
  2 in total

1.  The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C.

Authors:  L D Barber; L Percival; N M Valiante; L Chen; C Lee; J E Gumperz; J H Phillips; L L Lanier; J C Bigge; R B Parekh; P Parham
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

2.  Gorilla MHC class I gene and sequence variation in a comparative context.

Authors:  Jörg B Hans; Richard A Bergl; Linda Vigilant
Journal:  Immunogenetics       Date:  2017-03-22       Impact factor: 2.846

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.